Vericiguat in patients with heart failure across the spectrum of left ventricular ejection fraction: a patient-level, pooled meta-analysis of VITALITY-HFpEF and VICTORIA
C Chen, J Lv, C Liu - Frontiers in Endocrinology, 2024 - frontiersin.org
Vericiguat, the newest soluble guanylate cyclase (sGC) drug, is potentially beneficial in
treating heart failure (HF). However, most studies have only confirmed the significant impact …
treating heart failure (HF). However, most studies have only confirmed the significant impact …
[PDF][PDF] Heart Failure With Improved Ejection Fraction: Prevalence, Predictors, and Guideline-Directed Medical Therapy
SG Oommen, RK Man, K Talluri, M Nizam, T Kohir… - Cureus, 2024 - cureus.com
Recently, a new category of heart failure with improved ejection fraction (HFimpEF) has
emerged in the classification system. This is defined as the subgroup of patients with heart …
emerged in the classification system. This is defined as the subgroup of patients with heart …